Skip to main content

Table 1 Demographics, symptoms, risk factors

From: Transfemoral versus transapical approach for transcatheter aortic valve implantation: hospital outcome and risk factor analysis.

  Overall
(N = 180)
TA-TAVI
(N = 90)
TF-TAVI
(N = 90)
p
Mean age (years) 82 ± 8.6 80 ± 8.5 83 ± 8.4 0.014
Men 82 (46%) 45 (50%) 37 (41%) 0.231a
COPD 38 (21%) 29 (32%) 9 (10%) <0.001a
Peripheral vascular disease 91 (51%) 71 (79%) 20 (22%) <0.001a
Previous vascular surgery 17 (9%) 13 (14%) 4 (4%) 0.039
Coronary disease 90 (50%) 54 (60%) 36 (40%) 0.007a
Previous coronary surgery 27 (15%) 19 (21%) 8 (9%) 0.022a
Previous cardiac surgery 40 (22%) 25 (28%) 15 (17%) 0.073a
Previous coronary angioplasty/stenting 28 (16%) 13 (14%) 15 (17%) 0.681a
Hypertension 117 (65%) 56 (62%) 61 (68%) 0.435a
Chronic renal failure 75 (42%) 38 (42%) 37 (41%) 0.880a
Dialysis 7 (4%) 4 (4%) 3 (3%) 1
Previous stroke 20 (11%) 11 (12%) 9 (10%) 0.635a
Diabetes (insulin) 30 (17%) 18 (20%) 12 (13%) 0.230a
Liver disease (CHILD score) 5 (3%) 3 (3%) 2 (2%) 1
pacemaker implantation 21 (12%) 9 (10%) 12 (13%) 0.486a
Chest radiotherapy 16 (9%) 7 (8%) 9 (10%) 0.600a
Preoperative critical state 15 (8%) 13 (14%) 2 (2%) 0.005
Porcelain aorta 12 (13%) 12 (13%) 0 (0%) 1
logistic Euro-SCORE (%) 31 ± 16 36 ± 15 25 ± 14 <0.001
  1. Data presented as mean ± SD or N (%)
  2. a Chi2 value, otherwise it’s a Fischer test or a T-Test value
  3. COPD Chronic Obstructive Pulmonary Disease